192 related articles for article (PubMed ID: 32448607)
21. Wnt activation promotes neuronal differentiation of glioblastoma.
Rampazzo E; Persano L; Pistollato F; Moro E; Frasson C; Porazzi P; Della Puppa A; Bresolin S; Battilana G; Indraccolo S; Te Kronnie G; Argenton F; Tiso N; Basso G
Cell Death Dis; 2013 Feb; 4(2):e500. PubMed ID: 23429286
[TBL] [Abstract][Full Text] [Related]
22. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
[TBL] [Abstract][Full Text] [Related]
23. Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity.
Brown DV; Filiz G; Daniel PM; Hollande F; Dworkin S; Amiridis S; Kountouri N; Ng W; Morokoff AP; Mantamadiotis T
PLoS One; 2017; 12(2):e0172791. PubMed ID: 28241049
[TBL] [Abstract][Full Text] [Related]
24. Brain tumor stem cells from an adenoid glioblastoma multiforme.
Oka N; Soeda A; Noda S; Iwama T
Neurol Med Chir (Tokyo); 2009 Apr; 49(4):146-50; discussion 150-1. PubMed ID: 19398857
[TBL] [Abstract][Full Text] [Related]
25. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
[TBL] [Abstract][Full Text] [Related]
26. Rhodiola crenulata inhibits Wnt/β-catenin signaling in glioblastoma.
Mora MC; Bassa LM; Wong KE; Tirabassi MV; Arenas RB; Schneider SS
J Surg Res; 2015 Aug; 197(2):247-55. PubMed ID: 25998182
[TBL] [Abstract][Full Text] [Related]
27. A CD133-AKT-Wnt signaling axis drives glioblastoma brain tumor-initiating cells.
Manoranjan B; Chokshi C; Venugopal C; Subapanditha M; Savage N; Tatari N; Provias JP; Murty NK; Moffat J; Doble BW; Singh SK
Oncogene; 2020 Feb; 39(7):1590-1599. PubMed ID: 31695152
[TBL] [Abstract][Full Text] [Related]
28. Targeting Wnt/β-catenin-mediated upregulation of oncogenic NLGN3 suppresses cancer stem cells in glioblastoma.
Yun EJ; Kim D; Kim S; Hsieh JT; Baek ST
Cell Death Dis; 2023 Jul; 14(7):423. PubMed ID: 37443071
[TBL] [Abstract][Full Text] [Related]
29. Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy?
Behrooz AB; Syahir A
Front Oncol; 2021; 11():642719. PubMed ID: 33869033
[TBL] [Abstract][Full Text] [Related]
30. Comparison between cells and cancer stem-like cells isolated from glioblastoma and astrocytoma on expression of anti-apoptotic and multidrug resistance-associated protein genes.
Jin F; Zhao L; Zhao HY; Guo SG; Feng J; Jiang XB; Zhang SL; Wei YJ; Fu R; Zhao JS
Neuroscience; 2008 Jun; 154(2):541-50. PubMed ID: 18462887
[TBL] [Abstract][Full Text] [Related]
31. Astrocyte Elevated Gene-1 Regulates β-Catenin Signaling to Maintain Glioma Stem-like Stemness and Self-Renewal.
Hu B; Emdad L; Kegelman TP; Shen XN; Das SK; Sarkar D; Fisher PB
Mol Cancer Res; 2017 Feb; 15(2):225-233. PubMed ID: 27903708
[TBL] [Abstract][Full Text] [Related]
32. CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component.
Kahlert UD; Bender NO; Maciaczyk D; Bogiel T; Bar EE; Eberhart CG; Nikkhah G; Maciaczyk J
Folia Neuropathol; 2012; 50(4):357-68. PubMed ID: 23319191
[TBL] [Abstract][Full Text] [Related]
33. Biomimetic brain tumor niche regulates glioblastoma cells towards a cancer stem cell phenotype.
Liu YC; Lee IC; Chen PY
J Neurooncol; 2018 May; 137(3):511-522. PubMed ID: 29357090
[TBL] [Abstract][Full Text] [Related]
34. The ID1-CULLIN3 Axis Regulates Intracellular SHH and WNT Signaling in Glioblastoma Stem Cells.
Jin X; Jeon HM; Jin X; Kim EJ; Yin J; Jeon HY; Sohn YW; Oh SY; Kim JK; Kim SH; Jung JE; Kwak S; Tang KF; Xu Y; Rich JN; Kim H
Cell Rep; 2016 Aug; 16(6):1629-1641. PubMed ID: 27477274
[TBL] [Abstract][Full Text] [Related]
35. Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome.
Sandberg CJ; Altschuler G; Jeong J; Strømme KK; Stangeland B; Murrell W; Grasmo-Wendler UH; Myklebost O; Helseth E; Vik-Mo EO; Hide W; Langmoen IA
Exp Cell Res; 2013 Aug; 319(14):2230-43. PubMed ID: 23791939
[TBL] [Abstract][Full Text] [Related]
36. Down-expression of miR-154 suppresses tumourigenesis in CD133(+) glioblastoma stem cells.
Yang L; Yan Z; Wang Y; Ma W; Li C
Cell Biochem Funct; 2016 Aug; 34(6):404-13. PubMed ID: 27338789
[TBL] [Abstract][Full Text] [Related]
37. Sialidase NEU4 is involved in glioblastoma stem cell survival.
Silvestri I; Testa F; Zappasodi R; Cairo CW; Zhang Y; Lupo B; Galli R; Di Nicola M; Venerando B; Tringali C
Cell Death Dis; 2014 Aug; 5(8):e1381. PubMed ID: 25144716
[TBL] [Abstract][Full Text] [Related]
38. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
39. Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/β-catenin signaling.
Liu X; Gao Q; Zhao N; Zhang X; Cui W; Sun J; Fu J; Hao J
Mol Carcinog; 2018 Apr; 57(4):494-502. PubMed ID: 29240260
[TBL] [Abstract][Full Text] [Related]
40. Extracellular Vesicles Released by Glioblastoma Cells Stimulate Normal Astrocytes to Acquire a Tumor-Supportive Phenotype Via p53 and MYC Signaling Pathways.
Hallal S; Mallawaaratchy DM; Wei H; Ebrahimkhani S; Stringer BW; Day BW; Boyd AW; Guillemin GJ; Buckland ME; Kaufman KL
Mol Neurobiol; 2019 Jun; 56(6):4566-4581. PubMed ID: 30353492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
